Stay updated on Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record for the bempegaldesleukin plus nivolumab study is now displayed, including its completed status, participation criteria, study design and outcomes, participating locations, and study documents.
    Difference
    86%
    Check dated 2026-11-08T05:36:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The study record remains inaccessible behind a 403 Forbidden page. The footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T03:19:52.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T03:54:58.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The revision number in the footer changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T03:13:53.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T05:22:37.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the trial details, with added HTML indicating a 403 state. This means the NCT03785925 record is currently inaccessible on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-20T01:57:46.000Z thumbnail image

Stay in the know with updates to Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.